CLINICAL OBSERVATIONS WITH 1,6-BIS(β-CHLOROETHYLAMINO)-1,6-DEOXY-D-MANNITOL DIHYDROCHLORIDE (BCM) IN MALIGNANT DISEASES
- 1 April 1958
- journal article
- research article
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 68 (3), 1164-1180
- https://doi.org/10.1111/j.1749-6632.1958.tb42678.x
Abstract
No abstract availableThis publication has 16 references indexed in Scilit:
- Clinical Trials of p-(Di-2-chloroethylamine)-phenylbutyric Acid (CB 1348) in Malignant LymphomaBMJ, 1955
- STUDIES ON THE ANTI-TUMOUR ACTIVITY OF p-DI-(2-CHLOROETHYL) AMINOPHENYLALANINE (SARCOLYSINE)The Lancet, 1955
- Möglichkeiten und Grenzen der Therapie des Krebses - vom Standpunkt der experimentellen Forschung1Deutsche Medizinische Wochenschrift (1946), 1954
- Cyto-active amino-acid and peptide derivatives. Part I. Substituted phenylalaninesJournal of the Chemical Society, 1954
- 486. Aryl-2-halogenoalkylamines. Part XII. Some carboxylic derivatives of NN-di-2-chloroethylanilineJournal of the Chemical Society, 1953
- Experimental Studies on Chemotherapy of Malignant Growth Employing Yoshida Sarcoma AnimalsProceedings of the Japan Academy, 1951
- A TRIAL OF $beta;-NAPHTHYLDI-2-CHLOROETHYLAMINE (R48) IN LEUKqMIA, HODGKIN'S DISEASE, AND ALLIED DISEASESThe Lancet, 1950
- The growth-inhibitory and carcinogenic properties of 4-aminostilbene and derivativesPhilosophical Transactions of the Royal Society of London. Series A, Mathematical and Physical Sciences, 1948
- NITROGEN MUSTARDS IN THE TREATMENT OF NEOPLASTIC DISEASEJAMA, 1946
- The Biological Actions and Therapeutic Applications of the B-Chloroethyl Amines and SulfidesScience, 1946